Esperite N.V. appoints EY as external auditor
(Thomson Reuters ONE) -
Esperite N.V. (Euronext: ESP, 'Esperite', or 'the Group'), the European leader
in stem cells cryopreservation, now entering the fields of predictive medicine
and translational regenerative medicine R&D, announces that all resolutions of
today's extra-ordinary general meeting of shareholders ("EGM") were passed and
that EY Accountants LLP was appointed as external auditor for a term of 1-year
Enquiries: Esperite: + 31 (0) 575 548 998
Frédéric Amar, Chief Executive Officer
About Esperite (www.esperite.com)
Esperite, the leading international company in regenerative and predictive
medicine. Its family stem cell bank, CryoSave, stores almost 275,000 samples
from umbilical cord blood and cord tissue. There are already many diseases
treatable by the use of stem cells, and the number of treatments will only
increase. Esperite has cryopreserved samples from over 70 countries on six
continents, with ultra-modern processing and storage facilities in Belgium,
Switzerland, Germany, Dubai, South Africa and Portugal.
PDF: Press Release EGM:
http://hugin.info/143308/R/1881600/663701.pdf
This announcement is distributed by GlobeNewswire on behalf of
GlobeNewswire clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Esperite N.V. via GlobeNewswire
[HUG#1881600]
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
Datum: 18.12.2014 - 19:04 Uhr
Sprache: Deutsch
News-ID 360611
Anzahl Zeichen: 1830
contact information:
Town:
Zutphen
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 357 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Esperite N.V. appoints EY as external auditor"
steht unter der journalistisch-redaktionellen Verantwortung von
Esperite N.V. (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).





